Similar articles

• Ventricular fibrillation induced by xipamide.

  Altmann P, Hamblin JJ. Altmann P, et al. Br Med J (Clin Res Ed). 1982 Feb 13;284(6314):494. doi: 10.1136/bmj.284.6314.494. Br Med J (Clin Res Ed). 1982. PMID: 6800510 Free PMC article. No abstract available.
• QT interval prolongation and torsade de pointes associated with indapamide.

  Letsas KP, Alexanian IP, Pappas LK, Kounas SP, Efremidis M, Sideris A, Kardaras F. Letsas KP, et al. Int J Cardiol. 2006 Oct 10;112(3):373-4. doi: 10.1016/j.ijcard.2005.07.055. Epub 2005 Nov 2. Int J Cardiol. 2006. PMID: 16260053
• Hypokalaemia and xipamide.

  [No authors listed] [No authors listed] Br Med J (Clin Res Ed). 1982 Mar 27;284(6320):975. Br Med J (Clin Res Ed). 1982. PMID: 6802373 Free PMC article. No abstract available.
• Indapamide sustained release: a review of its use in the treatment of hypertension.

  Robinson DM, Wellington K. Robinson DM, et al. Drugs. 2006;66(2):257-71. doi: 10.2165/00003495-200666020-00011. Drugs. 2006. PMID: 16451099 Review.
• Quality of life during treatment of hypertensive patients with diuretics.

  Van Hoof R, Amery A, Fagard R, Staessen J. Van Hoof R, et al. Acta Cardiol. 1990;45(5):393-401. Acta Cardiol. 1990. PMID: 2281742 Review. No abstract available.